Oxford Bioscience leads round in Coherex
Boston-based venture capital firm Oxford Bioscience Partners was one of the lead investors in a $16.5 million funding round for Coherex Medical Inc. Joining Oxford Bioscience in the Series B financing was Tullis Health Investors, a Stamford, Conn.-based venture capital firm focused on the health-care industry. feeds.bizjournals.com |
Woodforest tops bank brand survey
For the second-straight year, Woodforest National Bank ranks as the most-recognized brand nationwide among mid-size banks with assets of between $2 billion and $30 billion, according to a financial services marketing research firm. feeds.bizjournals.com |
Orange shows 02's Apple iPhone is not the only fruit (at FT.com)
Exclusive goes mass-market. Apple's iPhone, once only selectively available, is about to roll out in such far-flung and impenetrable places as South Korea, China . . . and, for Brits, the local Orange or Vodafone store. us.rd.yahoo.com |
How Some Investors Ruin a Great Fund (Morningstar.com)
Volatile funds push all the wrong emotional buttons. us.rd.yahoo.com |
Hedge fund scandals (at FT.com)
Short-selling hedge funds, Morgan Stanley's chief financial officer supposedly said during the depths of last year's crisis, are like "cold blooded reptiles. They eat what's in front of them." us.rd.yahoo.com |